Sorvor Elizabeth, Owiredu William K B A, Okyere Perditer, Annani-Akollor Max Efui, Donkor Sampson, Bannor Richard, Sorvor Felix B K, Ephraim Richard K D
Department of Molecular Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Suntreso Government Hospital, Kumasi, Ghana.
Front Clin Diabetes Healthc. 2022 Aug 9;3:881202. doi: 10.3389/fcdhc.2022.881202. eCollection 2022.
Although traditional tests such as serum urea, creatinine, and microalbuminuria have been widely employed in the diagnosis of diabetic nephropathy, their sensitivity and accuracy are limited because kidney damage precedes the excretion of these biomarkers. This study investigated the role of serum free light chains in the disease manifestation of diabetic nephropathy.
Using a cross-sectional design we recruited 107 diabetes mellitus out-patients who visited the Diabetes and Renal Disease Clinics at the Komfo Anokye Teaching Hospital, Manhyia District Hospital, and Suntreso Government Hospital all in Ghana from November 2019 to February 2020. Five (5) mls of blood was collected from each participant and analyzed for fasting blood glucose (FBG) urea, creatinine, immunoglobulin free light chains. Urine samples were obtained and analyzed for albumin. Anthropometric characteristics were also measured. Data were analyzed using descriptive analysis, analysis of variance (ANOVA) test, Tukey HSD , and Kruskal Wallis test. Chi-squared test was used to examine if there are significant associations with the indicators of interest. In addition, Spearman's correlation was used to test for associations between appropriate variables. Receiver operating characteristic analysis (ROC) was also performed to assess the diagnostic performance of free light chains.
The mean age of studied participants was 58.2 years (SD: ± 11.1), 63.2% were females and most of the participants were married (63.0%). The mean FBG of the studied participants was 8.0mmol/L (SD: ± 5.86), and the average duration of diabetes mellitus (DM) was 11.88 years (SD: ± 7.96). The median serum Kappa, Lambda, and Kappa: Lambda ratios for the studied participants were 18.51 (15.63-24.18), 12.19(10.84-14.48), and 1.50(1.23-1.86) respectively. A positive correlation was observed between albuminuria and; Kappa (rs=0.132; p=0.209), and Lambda (rs=0.076; p=0.469). However, a negative correlation was observed between albuminuria and K: L ratio (rs=-0.006; p=0.956).
The current study observed an increasing trend in the levels of free light chains and degree of diabetic nephropathy, although not statistically significant. The exploration of serum free light chains as a better marker of diabetic nephropathy showed very promising results but further studies are required to elucidate its predictive value as a diagnostic tool for diabetic nephropathy.
尽管传统检测方法如血清尿素、肌酐和微量白蛋白尿已广泛应用于糖尿病肾病的诊断,但由于肾脏损伤先于这些生物标志物的排泄,其敏感性和准确性有限。本研究调查了血清游离轻链在糖尿病肾病疾病表现中的作用。
采用横断面设计,我们招募了107名糖尿病门诊患者,他们于2019年11月至2020年2月期间就诊于加纳的孔福·阿诺凯教学医院、曼希亚区医院和孙特雷索政府医院的糖尿病和肾脏疾病诊所。从每位参与者采集5毫升血液,分析空腹血糖(FBG)、尿素、肌酐、免疫球蛋白游离轻链。获取尿液样本并分析白蛋白。还测量了人体测量特征。数据采用描述性分析、方差分析(ANOVA)检验、Tukey HSD检验和Kruskal Wallis检验进行分析。卡方检验用于检查是否与感兴趣的指标存在显著关联。此外,Spearman相关性用于检验适当变量之间的关联。还进行了受试者工作特征分析(ROC)以评估游离轻链的诊断性能。
研究参与者的平均年龄为58.2岁(标准差:±11.1),63.2%为女性,大多数参与者已婚(63.0%)。研究参与者的平均FBG为8.0mmol/L(标准差:±5.86),糖尿病(DM)的平均病程为11.88年(标准差:±7.96)。研究参与者的血清κ、λ和κ:λ比值中位数分别为18.51(15.63 - 24.18)、12.19(10.84 - 14.48)和1.50(1.23 - 1.86)。观察到白蛋白尿与κ(rs = 0.132;p = 0.209)和λ(rs = 0.076;p = 0.469)之间呈正相关。然而,观察到白蛋白尿与κ:λ比值之间呈负相关(rs = -0.006;p = 0.956)。
本研究观察到游离轻链水平和糖尿病肾病程度呈上升趋势,尽管无统计学意义。将血清游离轻链作为糖尿病肾病更好标志物的探索显示出非常有前景的结果,但需要进一步研究以阐明其作为糖尿病肾病诊断工具的预测价值。